Skip to main content

View full-text article in PMC

. 2023 Nov 27;15(11):2423–2429. doi: 10.4240/wjgs.v15.i11.2423

Table 3.

Changes of polycystic ovary syndrome related indexes before and after operation

Time	Estradiol (pg/dL)	Testosterone (ng/mL)	Insulin (mIU/mL)	LH (U/L)	FSH (U/L)	LH/FSH
Preoperative	81.1 ± 25.6	0.72 ± 0.32	34.2 ± 16.0	6.1 ± 2.0	4.8 ± 1.6	1.3 ± 0.6
1 mo after operation	83.4 ± 21.2	0.68 ± 0.29^a	30.3 ± 12.8^a	6.3 ± 1.8^a	5.3 ± 2.1	1.1 ± 0.5^a
3 mo after operation	78.7 ± 18.8	0.57 ± 0.24^a	24.8 ± 9.2^a	5.8 ± 2.4^a	5.5 ± 1.8	1.1 ± 0.5^a
6 mo after operation	82.6 ± 16.4	0.51 ± 0.25^a	15.8 ± 6.1^a	5.5 ± 2.2^a	5.0 ± 2.5	0.9 ± 0.4^a
12 mo after operation	89.2 ± 29.3	0.43 ± 0.19^a	9.0 ± 2.5^a	4.4 ± 1.9^a	3.8 ± 2.3	0.7 ± 0.4^a

^a

P < 0.05, and at each time point after operation, it was compared with that before operation.

Compared with that before operation. LH: Luteinizing hormone; FSH: Follicle stimulating hormone.